Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals

OBJECTIVE: Anti-HBe seroconversion and HBsAg loss are important therapeutic endpoints in patients with hepatitis B virus (HBV) infection. Quantitative measures of hepatitis B surface antigen (qHBsAg) and e antigen (qHBeAg) have been identified as potentially useful indicators of therapeutic response...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthews, Gail V., Ali, Rachel J., Avihingsanon, Anchalee, Amin, Janaki, Hammond, Rachel, Bowden, Scott, Lewin, Sharon R., Sasadeusz, Joe, Littlejohn, Margaret, Locarnini, Stephen L., Ruxrungtham, Kiat, Dore, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622017/
https://www.ncbi.nlm.nih.gov/pubmed/23593455
http://dx.doi.org/10.1371/journal.pone.0061297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622017/
https://www.ncbi.nlm.nih.gov/pubmed/23593455
http://dx.doi.org/10.1371/journal.pone.0061297

Ejemplares similares